Category Archives: Gilead

  1. HIV/AIDS Organizations Tell FDA and Gilead Sciences: Don’t Delay HIV Prevention for Gay and Bisexual Men and Transgender Women

    [Press Release – October 18, 2011] Thirteen prominent U.S. HIV/AIDS organizations have issued an open letter to the U.S. Food and Drug Administration and Gilead Sciences calling for prompt regulatory review of pre-exposure prophylaxis (PrEP) for HIV prevention in gay and bisexual men and transgender women (men who have sex with men, or MSM). The letter urges Read More >>

    FDA, gay men, Gilead, HIV/AIDS. pre-exposure prophylaxis, IRMA, new prevention technologies, PrEP, transgendered
  2. AIDS Health Foundation (AHF) Questions Truvada’s Use as PrEP

    via Business Wire News Releases, by AIDS Healthcare Foundation AIDS Healthcare Foundation (AHF) unveiled a new print ad today that lays out data on the use of Gilead’s blockbuster HIV treatment drug Truvada as a pre-exposure prophylaxis (PrEP) or HIV prevention pill raising questions about the wisdom of pursuing approval by the U.S. Food & Drug Administration Read More >>

    Chicago, FDA, Gilead, lgbt community, Los Angeles, New York, PrEP, Truvada
  3. HIV drug-prevention strategy carries risks

    Via Nature News, by Erika Check Hayden. When the US Food and Drug Administration approved Viagra in 1998, officials never considered one possible side effect of the drug: higher rates of sexually transmitted diseases among men who, thanks to Viagra, would become more sexually active. A powerful tool in the fight against HIV is raising similar questions Read More >>

    FDA, Gilead, pre-exposure prophylaxis, PrEP, Truvada, Viagra
  4. AIDS conference opens in Rome

    This the beginning of IRMA’s coverage of the IAS conference in Rome which opened yesterday, and which is being attended by several IRMA advocates. Via Associated Press, by Alessandra Rizzo. The head of the United Nations AIDS program called Sunday for an increase in access to drugs that help treat or prevent the spread of the disease, Read More >>

    Africa, Gilead, HIV/AIDS, HIV/AIDS policy, IAS, IAS 2011, Rome, Treatment, UNAIDS, WHO
  5. PrEP Media Round-Up – It Works for Heterosexuals Too!

    [UPDATED JULY 18] The exciting news was announced last week that pre-exposure prophylaxis has been shown to work for heterosexual men and women as well as MSM. This is HUGE for HIV prevention. Below is a selection of news items and press releases we have collected on the two studies that reported out last week. In the comments feel Read More >>

    Africa, Gilead, heterosexual epidemic, HIV, HIV transmission, HIV/AIDS, HIV/AIDS policy, iPrEx, new prevention technologies, Partners PrEP, PrEP, prevention, Tenofovir, Truvada
  6. Project Inform Reports: Financing Recommendations for PrEP

    Project Inform recently released a report titled Financing and Delivery Mechanisms to Increase Pre-Exposure Prophylaxis (PrEP) Access in Populations at High-Risk of HIV Infection. Available here, the report discusses issues related to financing for PrEP to ensure that it becomes a viable, accessible prevention method for MSM. Here as an excerpt from the executive summary of the Read More >>

    ARV, ARVs, Gilead, HIV/AIDS, HIV/AIDS policy, HIV/AIDS. pre-exposure prophylaxis, PrEP, Truvada
  7. PODCAST: The Battle Over HIV Prevention – IRMA’s Jim Pickett jumps in

    Last time there was a lot of fuss over a little blue pill, Bob Dole was doing Viagra ads on TV. via Feast of Fun Check out the podcast now. The AIDS Healthcare Foundation launched a national ad campaign to discredit PrEP or Pre Exposure Prophylaxis, a new HIV prevention technique that involves taking Truvada (an existing Read More >>

    Gilead, HIV/AIDS policy, Jim Pickett, new prevention technologies, PrEP, Truvada
  8. FORUM: The Magic Pill – How far would you go to stay HIV negative?

    If you are in Seattle, please make it a point to attend this forum Wednesday, April 27 on the potential promises, and possible perils, of using HIV meds for prevention… Check out the FB invite [If an item is not written by an IRMA member, it should not be construed that IRMA has taken a position on Read More >>

    Gilead, HIV/AIDS policy, HIV/AIDS. pre-exposure prophylaxis, new prevention technologies, PrEP, Truvada